- Home
- SILO vs TRIB Comparison
SILO vs TRIB Comparison
Compare SILO & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- TRIB
- Stock Information
- Founded
- SILO 2010
- TRIB 1992
- Country
- SILO United States
- TRIB Ireland
- Employees
- SILO N/A
- TRIB N/A
- Industry
- SILO Apparel
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SILO Consumer Discretionary
- TRIB Health Care
- Exchange
- SILO Nasdaq
- TRIB Nasdaq
- Market Cap
- SILO 5.9M
- TRIB 5.4M
- IPO Year
- SILO N/A
- TRIB N/A
- Fundamental
- Price
- SILO $0.68
- TRIB $1.21
- Analyst Decision
- SILO
- TRIB
- Analyst Count
- SILO 0
- TRIB 0
- Target Price
- SILO N/A
- TRIB N/A
- AVG Volume (30 Days)
- SILO 289.1K
- TRIB 13.1M
- Earning Date
- SILO 08-13-2025
- TRIB 11-14-2025
- Dividend Yield
- SILO N/A
- TRIB N/A
- EPS Growth
- SILO N/A
- TRIB N/A
- EPS
- SILO N/A
- TRIB N/A
- Revenue
- SILO $72,102.00
- TRIB $61,555,000.00
- Revenue This Year
- SILO $1.86
- TRIB $13.51
- Revenue Next Year
- SILO N/A
- TRIB $13.14
- P/E Ratio
- SILO N/A
- TRIB N/A
- Revenue Growth
- SILO N/A
- TRIB 8.31
- 52 Week Low
- SILO $0.41
- TRIB $0.48
- 52 Week High
- SILO $3.37
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- SILO 55.60
- TRIB 49.69
- Support Level
- SILO $0.58
- TRIB $1.42
- Resistance Level
- SILO $0.65
- TRIB $1.58
- Average True Range (ATR)
- SILO 0.04
- TRIB 0.11
- MACD
- SILO 0.00
- TRIB -0.06
- Stochastic Oscillator
- SILO 83.31
- TRIB 22.80
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.